Literatur

Breier F, Klade H.
Lymphozytenproliferationstest bei Patienten mit kutanen Veränderungen der Lyme Borreliose.
Wiener Med Wochenschr 1995; 7/8:170-4

Schmidt B, Aberer E, Stockenhuber C, Klade H, Breier F, Luger A.
Detection of B.burgdorferi-DNA by polymerase-chain reaction in ther urine and breast milk of patients with Lyme borreliosis.
Diagn Microb Infec Dis 1995;21:121-28

Schmidt BL, Aberer E, Stockenhuber C, Wagner C, Klade H, Breier F, Luger A.
Detection of Borrelia burgdorferi-DNA in urine from patients with Lyme borreliosis.
J Spir and Tick-borne Dis 1995;2:76-81.

Aberer A, Breier F, Stanek G, Schmidt B.
Success and failure in the treatment of acrodermatitis chronica atrophicans.
Infection 1996;24:85-7.

Breier F, Klade H, Aberer E.
Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
Br J Dermatol 1996;134:285-91.

Breier F, Kunz G, Klade H, Stanek G, Aberer E.
Erythema chronicum migrans: Three week treatment for prevetion of late Lyme borreliosis.
Infection 1996;24:69-72.

Breier F, Schmidt B, Stanek G, Aberer E.
Sclerosing and granulomatous skin lesions in Borrelia burgdorferi infection.
Acta Dermatolvenerologica APA 1996;5:117-22.

Aberer E, Schmidt B, Fang-Kircher S, Kinacyian T, Breier F, Luger A.
Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma anulare and lichen sclerosus et atrophicus.
Arch Dermatol 1999;135:210-2.

Breier F, Aberer E, Stanek G, Khanakah G, Schlick A, Tappeiner G.
Isolation of Borrelia afzelii from circumscribed scleroderma
Br J Dermatol 1999; 140:925-30.

Stanek G, Breier F, Menzinger G, Schaar B, Hafner M, Partsch H.
Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Wien Klin Wochenschr 1999;111/22-23:951-6.

Breier F, Kunz G, Aberer E, Khanakah G, Schmidt B, Stanek G, Tappeiner G.
Isolation and PCR-typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalised, ulcerating, bullous lichen sclerosus.
Br J Dermatol 2001;144(2):387-392.